An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Maicol Mancini, Hilah Gal, Nadège Gaborit, Luigi Mazzeo, Donatella Romaniello, Tomer Meir Salame, Moshit Lindzen, Georg Mahlknecht, Yehoshua Enuka, Dominick GA Burton, Lee Roth, Ashish Noronha, Ilaria Marrocco, Dan Adreka, Raya Eilam Altstadter, Emilie Bousquet, Julian Downward, Antonio Maraver, Valery Krizhanovsky, Yosef Yarden

Journal title: EMBO Molecular Medicine

Journal number: 10/2

Journal publisher: John Wiley & Sons Ltd.

Published year: 2018

Published pages: 294-308

DOI identifier: 10.15252/emmm.201708076

ISSN: 1757-4676